Charles Frischer on X
$OMER Comments from today's investor day with Novo. I think these words are quite bullish for Omeros and their partnership with Novo. https://t.co/ov8OF0gNlQ
NASDAQ
Omeros CORP
OMER
2 stories
$1.4B Market cap · 2026-10-09
Charles Frischer on X
$OMER My friend Matt just sent this to me. Great review of how Yartemlia works. Narsoplimab Mechanism of Action: Fighting Transplant–Associated Thrombot... https://t.co/cxTshzo3Qq via @YouTube
